Track market-moving stories before they get noisy

Posted by Defense World Staff on Jul 22nd, 2026

D.A. Davidson & CO. raised its holdings in Omega Healthcare Investors, Inc. (NYSE:OHI – Free Report) by 131.8% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 38,750 shares of the real estate investment trust’s stock after purchasing an additional 22,030 shares during the quarter. D.A. Davidson & CO.’s holdings in Omega Healthcare Investors were worth $1,698,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently bought and sold shares of OHI. Resources Management Corp CT ADV grew its holdings in shares of Omega Healthcare Investors by 300.0% during the fourth quarter. Resources Management Corp CT ADV now owns 600 shares of the real estate investment trust’s stock worth $27,000 after purchasing an additional 450 shares during the last quarter. Ascentis Independent Advisors bought a new position in shares of Omega Healthcare Investors in the first quarter valued at about $35,000. Gunpowder Capital Management LLC dba Oliver Wealth Management bought a new position in shares of Omega Healthcare Investors in the fourth quarter valued at about $37,000. Smartleaf Asset Management LLC lifted its position in Omega Healthcare Investors by 40.9% during the 2nd quarter. Smartleaf Asset Management LLC now owns 924 shares of the real estate investment trust’s stock worth $34,000 after buying an additional 268 shares in the last quarter. Finally, Rothschild Investment LLC lifted its position in Omega Healthcare Investors by 283.7% during the 4th quarter. Rothschild Investment LLC now owns 944 shares of the real estate investment trust’s stock worth $42,000 after buying an additional 698 shares in the last quarter. Institutional investors and hedge funds own 65.25% of the company’s stock.

Wall Street Analyst Weigh In Several research firms have weighed in on OHI. Barclays initiated coverage on shares of Omega Healthcare Investors in a research report on Tuesday, July 7th. They issued an “underweight” rating and a $51.00 price objective for the company. Citigroup reiterated a “market perform” rating on shares of Omega Healthcare Investors in a research report on Monday, June 15th. Raymond James Financial assumed coverage on shares of Omega Healthcare Investors in a research note on Tuesday, June 16th. They set an “outperform” rating and a $50.00 price target on the stock. Scotiabank lowered their price target on shares of Omega Healthcare Investors from $50.00 to $47.00 and set a “sector perform” rating for the company in a report on Thursday, June 18th. Finally, Truist Financial dropped their price objective on shares of Omega Healthcare Investors from $48.00 to $46.00 and set a “hold” rating for the company in a research report on Tuesday, June 9th. Five research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $48.50.

Check Out Our Latest Stock Analysis on Omega Healthcare Investors

Omega Healthcare Investors Price Performance Omega Healthcare Investors stock opened at $50.52 on Wednesday. The business’s 50-day simple moving average is $47.28 and its 200 day simple moving average is $46.31. The stock has a market cap of $15.04 billion, a price-to-earnings ratio of 24.40, a P/E/G ratio of 2.12 and a beta of 0.58. Omega Healthcare Investors, Inc. has a 12-month low of $38.02 and a 12-month high of $50.75. The company has a quick ratio of 5.32, a current ratio of 5.32 and a debt-to-equity ratio of 0.81.

Omega Healthcare Investors (NYSE:OHI – Get Free Report) last announced its quarterly earnings data on Tuesday, April 28th. The real estate investment trust reported $0.47 earnings per share for the quarter, missing the consensus estimate of $0.49 by ($0.02). Omega Healthcare Investors had a return on equity of 11.86% and a net margin of 51.14%.The firm had revenue of $322.95 million for the quarter, compared to the consensus estimate of $264.07 million. During the same period in the prior year, the firm posted $0.75 earnings per share. The business’s revenue for the quarter was up 16.7% compared to the same quarter last year. Omega Healthcare Investors has set its FY 2026 guidance at 3.190-3.250 EPS. As a group, research analysts anticipate that Omega Healthcare Investors, Inc. will post 3.09 earnings per share for the current year.

Omega Healthcare Investors Dividend Announcement The firm also recently declared a quarterly dividend, which was paid on Friday, May 15th. Stockholders of record on Monday, May 4th were given a dividend of $0.67 per share. The ex-dividend date was Monday, May 4th. This represents a $2.68 annualized dividend and a dividend yield of 5.3%. Omega Healthcare Investors’s payout ratio is currently 129.47%.

About Omega Healthcare Investors (Free Report)

Omega Healthcare Investors, Inc is a real estate investment trust (REIT) that specializes in the ownership and management of healthcare-related facilities. The company’s core business involves acquiring and leasing long-term care properties, including skilled nursing facilities and assisted living communities, under net lease agreements. Its portfolio is designed to provide stable, inflation-protected cash flows from operators responsible for day-to-day property management.

Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega Healthcare Investors has grown its holdings to encompass hundreds of facilities across the United States, with a smaller presence in select international markets.

Featured Articles Five stocks we like better than Omega Healthcare Investors Confidence Is Back, But Earnings Show the Consumer Is Being Picky AeroVironment’s Stock Is Down, But Drone Demand Is Taking Off 3M’s Redemption Arc: Can Q2 Earnings Change the Narrative? 3 Photonics Companies Making Quantum Tech Possible Want to see what other hedge funds are holding OHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Omega Healthcare Investors, Inc. (NYSE:OHI – Free Report).

Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINECalifornia Public Employees Retirement System Reduces Stake in Mid-America Apartment Communities, Inc. $MAA

NEXT HEADLINE »RenaissanceRe Holdings Ltd. $RNR Shares Sold by California Public Employees Retirement System

Omega Healthcare (OHI) is a structurally advantaged healthcare REIT focused on skilled nursing and senior-care facilities, rated Buy for double-digit AFFO growth prospects. OHI benefits from an aging population, diversified operator base, and long lease terms, positioning it for sustained demand and rental income growth. Recent AFFO guidance was raised, with Q2 expectations for a 9% y/y AFFO/share increase and a consistent track record of modest quarterly beats.

Omega Healthcare Investors (OHI - Free Report) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices.

The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.

The power of a changing earnings picture in determining near-term stock price movements makes the Zacks rating system highly useful for individual investors, since it can be difficult to make decisions based on rating upgrades by Wall Street analysts. These are mostly driven by subjective factors that are hard to see and measure in real time.

Therefore, the Zacks rating upgrade for Omega Healthcare Investors basically reflects positivity about its earnings outlook that could translate into buying pressure and an increase in its stock price.

Most Powerful Force Impacting Stock PricesThe change in a company's future earnings potential, as reflected in earnings estimate revisions, and the near-term price movement of its stock are proven to be strongly correlated. The influence of institutional investors has a partial contribution to this relationship, as these big professionals use earnings and earnings estimates to calculate the fair value of a company's shares. An increase or decrease in earnings estimates in their valuation models simply results in higher or lower fair value for a stock, and institutional investors typically buy or sell it. Their transaction of large amounts of shares then leads to price movement for the stock.

Fundamentally speaking, rising earnings estimates and the consequent rating upgrade for Omega Healthcare Investors imply an improvement in the company's underlying business. Investors should show their appreciation for this improving business trend by pushing the stock higher.

Harnessing the Power of Earnings Estimate RevisionsAs empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock movements, tracking such revisions for making an investment decision could be truly rewarding. Here is where the tried-and-tested Zacks Rank stock-rating system plays an important role, as it effectively harnesses the power of earnings estimate revisions.

The Zacks Rank stock-rating system, which uses four factors related to earnings estimates to classify stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record, with Zacks Rank #1 stocks generating an average annual return of +25% since 1988. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here >>>> .

Earnings Estimate Revisions for Omega Healthcare InvestorsThis health care real estate investment trust is expected to earn $3.23 per share for the fiscal year ending December 2026, which represents no year-over-year change.

Analysts have been steadily raising their estimates for Omega Healthcare Investors. Over the past three months, the Zacks Consensus Estimate for the company has increased 0.8%.

Bottom LineUnlike the overly optimistic Wall Street analysts whose rating systems tend to be weighted toward favorable recommendations, the Zacks rating system maintains an equal proportion of "buy" and "sell" ratings for its entire universe of more than 4,000 stocks at any point in time. Irrespective of market conditions, only the top 5% of the Zacks-covered stocks get a "Strong Buy" rating and the next 15% get a "Buy" rating. So, the placement of a stock in the top 20% of the Zacks-covered stocks indicates its superior earnings estimate revision feature, making it a solid candidate for producing market-beating returns in the near term.

You can learn more about the Zacks Rank here >>>

The upgrade of Omega Healthcare Investors to a Zacks Rank #2 positions it in the top 20% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the near term.

Investors looking for stocks in the REIT and Equity Trust - Other sector might want to consider either Alpine Income (PINE - Free Report) or Omega Healthcare Investors (OHI - Free Report) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.

Everyone has their own methods for finding great value opportunities, but our model includes pairing an impressive grade in the Value category of our Style Scores system with a strong Zacks Rank. The Zacks Rank is a proven strategy that targets companies with positive earnings estimate revision trends, while our Style Scores work to grade companies based on specific traits.

Alpine Income and Omega Healthcare Investors are sporting Zacks Ranks of #2 (Buy) and #3 (Hold), respectively, right now. This means that PINE's earnings estimate revision activity has been more impressive, so investors should feel comfortable with its improving analyst outlook. But this is only part of the picture for value investors.

Value investors also try to analyze a wide range of traditional figures and metrics to help determine whether a company is undervalued at its current share price levels.

The Value category of the Style Scores system identifies undervalued companies by looking at a number of key metrics. These include the long-favored P/E ratio, P/S ratio, earnings yield, cash flow per share, and a variety of other fundamentals that help us determine a company's fair value.

PINE currently has a forward P/E ratio of 9.78, while OHI has a forward P/E of 14.89. We also note that PINE has a PEG ratio of 1.40. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. OHI currently has a PEG ratio of 1.97.

Another notable valuation metric for PINE is its P/B ratio of 1.03. The P/B ratio pits a stock's market value against its book value, which is defined as total assets minus total liabilities. For comparison, OHI has a P/B of 2.62.

Based on these metrics and many more, PINE holds a Value grade of B, while OHI has a Value grade of C.

PINE stands above OHI thanks to its solid earnings outlook, and based on these valuation figures, we also feel that PINE is the superior value option right now.

The aging of America continues to be an investable theme. And recent survey data from AARP gives investors a hint on where to direct their capital.

According to AARP, about 59 million Americans provided care for an adult family member, neighbor, or friend in 2024. That totaled 49.5 billion hours of care at a cost of around $1.01 trillion in annual economic value—a figure that exceeds the total for federal, state, and local Medicaid spending. 

This is a complex reality for caregivers in the “sandwich generation” who are in their 40s to early 60s. In many cases, they are balancing raising a family of their own, caring for elderly loved ones, and managing careers.

Get Savaria alerts:

But in many cases, informal caregiving remains the more affordable alternative to institutional or assisted living arrangements. These options often require Medicaid approval for those who qualify based on income and asset limits, or they result in significant out-of-pocket expenses for those who don't.

The U.S. Census Bureau estimates the 65-and-older population will nearly double by 2060. This is why investors should consider healthcare stocks with business models that provide relief for caregivers.

Omega Healthcare Investors Delivers Income as Senior Housing Demand ReboundsOmega Healthcare Investors Today

OHI

Omega Healthcare Investors

$45.77 +0.49 (+1.08%)

As of 03:59 PM Eastern

This is a fair market value price provided by Massive. Learn more.

52-Week Range$35.70▼

$49.33Dividend Yield5.86%

P/E Ratio22.11

Price Target$49.00

Omega Healthcare Investors NYSE: OHI is a real estate investment trust (REIT) that owns and manages healthcare-related facilities, including skilled nursing facilities and assisted living communities. It acquires and leases these properties under triple net agreements, in turn providing investors with stable, inflation-protected cash flow.

According to the National Investment Center for Seniors Housing & Care, senior housing, assisted living, and independent living occupancy rates are nearly back to pre-pandemic levels, suggesting that demand for those services is strengthening.

After a run-up of almost 25% in the last 12 months, OHI stock looks to have much of that growth already priced in. However, a moderate pullback in the past month helps strengthen the buy case. Analysts have been raising their price targets, but the consensus price target of $48 is only slightly higher than the OHI price as of this writing.

Many investors turn to REITs because of their reliable dividend payments. In the case of Omega Healthcare, the dividend yield is 5.8% and looks sustainable based on future earnings and cash flow estimates.

Addus HomeCare Is Positioned for Growth as In-Home Care Gains TractionAddus HomeCare Today

$93.28 +0.24 (+0.26%)

As of 04:00 PM Eastern

52-Week Range$87.95▼

$124.43P/E Ratio17.24

Price Target$131.00

Addus HomeCare NASDAQ: ADUS leans directly into the current need for home health care. Addus is a leading provider of home- and community-based care services that operates through a network of company-owned and franchise locations in the United States.

Shares of ADUS are down about 7% over the past year, but that might be a function of the company’s ongoing battle with states to secure Medicaid dollars. Addus has argued that personal care can be materially less expensive than nursing home placement, thereby conserving Medicaid dollars.

To that end, the company recently noted that Medicaid redeterminations are easing, which can provide a tailwind.

Addus posted year-over-year revenue and earnings growth in the last several quarters. That’s expected to continue, with analysts forecasting over 16% earnings growth in the next 12 months.

Despite a solid earnings report in November, ADUS stock sold off sharply and is trading near its 52-week low. That’s where investors may have an opportunity. Analysts are bullish with a consensus price target that is more than 40% higher than recent prices. The stock currently receives a Moderate Buy rating.

Savaria Capitalizes on Aging-in-Place Trend With Accessibility SolutionsSavaria Today

$20.83 -0.11 (-0.53%)

As of 03:00 PM Eastern

52-Week Range$14.23▼

$22.78Dividend Yield0.60%

P/E Ratio94.68

Savaria OTCMKTS: SISXF straddles the line between industrial stocks and medical stocks. The company sells home-accessibility products (e.g., stairlifts, elevators, and platform lifts) that support the aging-in-place industry.

Savaria’s products are on the front line of the home healthcare movement. Many family members or caregivers will initially look to make modifications to a loved one’s home before taking steps to find alternate living or care arrangements.

This trend is reflected in the company's revenue and earnings estimates, which partially explain why SISXF is up more than 90% over the past 12 months. The Canada-based company doesn’t receive heavy analyst coverage, but MarketBeat's data shows a Buy rating.

Adding to the appeal of SISXF is its monthly dividend, which paid out 4.67 cents per share in March 2026. That makes this stock a savvy choice for investors looking for a reliable compounder with the potential for future growth.

Should You Invest $1,000 in Savaria Right Now?Before you consider Savaria, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Savaria wasn't on the list.

While Savaria currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Investors interested in REIT and Equity Trust - Other stocks are likely familiar with Hudson Pacific Properties (HPP) and Omega Healthcare Investors (OHI). But which of these two stocks offers value investors a better bang for their buck right now?

-

HUNT VALLEY, Md.--(BUSINESS WIRE)--Omega Healthcare Investors, Inc. (NYSE:OHI) today announced that the Company’s Board of Directors declared a cash dividend of $0.67 per share on its common stock. The dividend is payable Friday, May 15, 2026, to common stockholders of record as of the close of business on Monday, May 4, 2026.

Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK and Canada. More information on Omega is available at www.omegahealthcare.com.

More News From Omega Healthcare Investors, Inc.

Back to Newsroom

Posted by Defense World Staff on Apr 24th, 2026

Evergreen Capital Management LLC boosted its holdings in Omega Healthcare Investors, Inc. (NYSE:OHI – Free Report) by 201.2% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 25,778 shares of the real estate investment trust’s stock after acquiring an additional 17,219 shares during the quarter. Evergreen Capital Management LLC’s holdings in Omega Healthcare Investors were worth $1,143,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in OHI. Royal Bank of Canada increased its position in Omega Healthcare Investors by 29.4% in the 1st quarter. Royal Bank of Canada now owns 144,339 shares of the real estate investment trust’s stock valued at $5,496,000 after acquiring an additional 32,798 shares during the period. Focus Partners Wealth increased its position in Omega Healthcare Investors by 3.1% in the 1st quarter. Focus Partners Wealth now owns 19,862 shares of the real estate investment trust’s stock valued at $756,000 after acquiring an additional 597 shares during the period. Sivia Capital Partners LLC acquired a new stake in Omega Healthcare Investors in the 2nd quarter valued at approximately $257,000. Guggenheim Capital LLC increased its position in Omega Healthcare Investors by 1.0% in the 2nd quarter. Guggenheim Capital LLC now owns 29,398 shares of the real estate investment trust’s stock valued at $1,077,000 after acquiring an additional 280 shares during the period. Finally, First Trust Advisors LP increased its position in Omega Healthcare Investors by 32.8% in the 2nd quarter. First Trust Advisors LP now owns 193,099 shares of the real estate investment trust’s stock valued at $7,077,000 after acquiring an additional 47,649 shares during the period. 65.25% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth Several research firms recently commented on OHI. Royal Bank Of Canada raised their target price on Omega Healthcare Investors from $44.00 to $47.00 and gave the company a “sector perform” rating in a research report on Tuesday, February 10th. Wells Fargo & Company raised their target price on Omega Healthcare Investors from $45.00 to $47.00 and gave the company an “equal weight” rating in a research report on Thursday, March 26th. Bank of America restated an “underperform” rating and issued a $46.00 target price (down from $52.00) on shares of Omega Healthcare Investors in a research report on Tuesday, April 14th. Weiss Ratings upgraded Omega Healthcare Investors from a “buy (b+)” rating to a “buy (a-)” rating in a research report on Tuesday. Finally, The Goldman Sachs Group started coverage on Omega Healthcare Investors in a research note on Friday, January 9th. They set a “buy” rating and a $54.00 price target for the company. One research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $47.83.

Get Our Latest Stock Analysis on Omega Healthcare Investors

Omega Healthcare Investors Price Performance NYSE:OHI opened at $46.36 on Friday. The business’s 50-day moving average price is $46.41 and its 200 day moving average price is $44.58. The firm has a market cap of $13.81 billion, a P/E ratio of 24.02, a PEG ratio of 2.00 and a beta of 0.59. Omega Healthcare Investors, Inc. has a 52-week low of $35.08 and a 52-week high of $49.14. The company has a quick ratio of 5.04, a current ratio of 5.04 and a debt-to-equity ratio of 0.78.

Omega Healthcare Investors Dividend Announcement The company also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Monday, May 4th will be issued a dividend of $0.67 per share. This represents a $2.68 dividend on an annualized basis and a yield of 5.8%. The ex-dividend date of this dividend is Monday, May 4th. Omega Healthcare Investors’s payout ratio is presently 138.86%.

Omega Healthcare Investors Company Profile (Free Report)

Omega Healthcare Investors, Inc is a real estate investment trust (REIT) that specializes in the ownership and management of healthcare-related facilities. The company’s core business involves acquiring and leasing long-term care properties, including skilled nursing facilities and assisted living communities, under net lease agreements. Its portfolio is designed to provide stable, inflation-protected cash flows from operators responsible for day-to-day property management.

Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega Healthcare Investors has grown its holdings to encompass hundreds of facilities across the United States, with a smaller presence in select international markets.

Recommended Stories Five stocks we like better than Omega Healthcare Investors Want to see what other hedge funds are holding OHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Omega Healthcare Investors, Inc. (NYSE:OHI – Free Report).

Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEOppenheimer Has Lowered Expectations for Ingredion (NYSE:INGR) Stock Price

NEXT HEADLINE »Evergreen Capital Management LLC Acquires 7,222 Shares of ServiceNow, Inc. $NOW

Completed $251 Million in New Investments in Q1 2026
Raises Full Year Adjusted FFO Guidance Mid-Point

HUNT VALLEY, Md.--(BUSINESS WIRE)--Omega Healthcare Investors, Inc. (NYSE: OHI) (the “Company” or “Omega”) announced today its results for the quarter ended March 31, 2026.

FIRST QUARTER 2026 AND RECENT HIGHLIGHTS

Net income for the quarter of $159 million, or $0.47 per diluted share, compared to $112 million, or $0.33 per diluted share, for Q1 2025. Adjusted Funds From Operations (“Adjusted FFO” or “AFFO”) for the quarter of $260 million, or $0.82 per diluted share, on 315 million weighted-average common shares outstanding, compared to $221 million, or $0.75 per diluted share, on 295 million weighted-average common shares outstanding, for Q1 2025. Funds Available for Distribution (“FAD”) for the quarter of $247 million, or $0.78 per diluted share, compared to FAD of $211 million, or $0.71 per diluted share, for Q1 2025. Completed $251 million of investments in Q1 consisting of $126 million in real estate acquisitions, $27 million in real estate loan fundings and $97 million of investments in unconsolidated entities, including the acquisition of a 9.9% equity interest in the Saber OpCo JV for $93 million. Issued 2 million common shares in Q1 for gross proceeds of $107 million. Completed $75 million in new investments in April 2026. 18 CommuniCare facilities expected to be sold in Q2 for $480 million. Nareit Funds From Operations (“Nareit FFO”), AFFO and FAD are supplemental non-GAAP financial measures the Company believes are useful in evaluating the performance of real estate investment trusts (“REITs”). Reconciliations and further information regarding these non-GAAP measures are provided at the end of this press release.

CEO COMMENTS

Taylor Pickett, Omega’s Chief Executive Officer, stated, “We are pleased to report strong first quarter results, with FAD per share up 9.5% over the same quarter last year. This reflects our continued accretive investment activity, augmented by active portfolio management. As a result of our strong start to 2026, we were able to increase the low end of our AFFO guidance, moving the midpoint up by two cents to $3.22.”

Mr. Pickett continued, “Our first quarter investments included both skilled nursing triple-net and senior housing RIDEA real estate investments, as well as, our equity investment in Saber, and our first investment in Canada. Additionally, we announced the expected sale of 18 skilled nursing facilities for proceeds of $480 million, which, when redeployed, we believe will add a further three cents to FAD. Each of these investment decisions reflect our relentless focus on driving shareholder value through innovative and thoughtful investments, while aligning our interests with our operating partners.”

Mr. Pickett concluded, “Overall, the backdrop continues to be favorable. Operating metrics remain strong, with coverage continuing to modestly improve in the quarter. Despite elevated interest in senior care real estate, the pipeline is very active, the team is highly engaged, and we have a cost of capital that should allow us to continue to accretively invest.”

FIRST QUARTER 2026 PORTFOLIO AND RECENT ACTIVITY

Operator Updates:

Genesis – As previously disclosed, Genesis Healthcare, Inc. (“Genesis”) filed for Chapter 11 bankruptcy protection on July 9, 2025. Since filing for bankruptcy, Genesis has made all required contractual rent and interest payments through April 2026. In March 2026, Omega agreed to provide $26.7 million in a new super-priority secured $80.0 million debtor-in-possession (“DIP”) financing. As of March 31, 2026, Omega funded $25.0 million under the new DIP financing. A portion of the proceeds was used to fully repay the $9.2 million of outstanding obligations due to Omega under the original DIP loan. In the first quarter of 2026, the Company recognized rental income of $13.3 million for contractual rent payments received from Genesis, and interest income of $7.0 million, consisting of $0.4 million of cash interest and $6.6 million of paid-in-kind interest.

Maplewood – In the first quarter of 2026, Maplewood Senior Living (along with affiliates “Maplewood”) paid $19.4 million in rent (compared to $18.9 million in the fourth quarter of 2025).

New Investments:

The following table presents investment activity:

Three Months Ended

Investment Activity ($000’s)

March 31, 2026

$ Amount

%

Real property

$

126,434

50.4

%

Real estate loan fundings

27,343

10.9

%

Investments in unconsolidated entities

96,996

38.7

%

Total real property and loan investments

$

250,773

100.0

%

$126 Million in Real Estate Acquisitions – In the first quarter of 2026, the Company acquired 15 facilities for aggregate consideration of $126.4 million, comprised of:

$120 Million in U.S. Real Estate Acquisitions – In two first quarter transactions, the Company acquired one senior housing facility in Alabama and 13 skilled nursing facilities (“SNFs”) in Georgia for aggregate consideration of $119.8 million. The Company will operate the Alabama facility, through a new third-party property manager, utilizing the REIT Investment Diversification and Empowerment Act of 2007 (“RIDEA”) structure. The 13 Georgia SNFs were leased to an existing operator with an initial cash yield of 10.6% and annual escalators of 2.5%. $7 Million U.K. Real Estate Acquisition – The Company acquired one care home in the U.K. for $6.6 million and leased it to an existing operator. The investment has an initial annual cash yield of 10.0% with annual escalators of 2.5%. $27 Million in Real Estate Loans – In the first quarter of 2026, the Company funded $27.3 million in real estate loans, comprised of:

$21 Million U.K. Mortgage Loan – The Company funded a new $21.3 million mortgage loan to an existing operator secured by a U.K care home. The loan has an interest rate of 13% and a maturity date in March 2027. $4 Million of Additional Fundings on Existing U.S Real Estate Loans – The Company funded $3.8 million of additional draws on existing U.S. real estate loans during the first quarter of 2026 at a weighted average interest rate of 10.7%. $2 Million of Fundings on Canada Development Loan – In the first quarter of 2026, the Company funded $2.2 million ($CAD $3.0 million) under a previously disclosed Canadian dollar denominated real estate loan, with maximum capacity of $62.8 million ($CAD $87.6 million), that was executed in December 2025. The proceeds of the loan will be utilized for the development of five long-term care facilities in Canada. The loan has an interest rate of 10.0% with a maturity date in December 2035. At Omega’s option, the loan is convertible into a 34.9% equity stake in the borrower. $97 Million of Investments in Unconsolidated Entities – In the first quarter of 2026, the Company funded $97.0 million of investments in several unconsolidated entities. The primary investment was a 9.9% equity interest in Saber Healthcare Holdings, LLC (“Saber”) that the Company acquired in January 2026 for $92.6 million in cash consideration. Omega will receive minimum quarterly cash distributions equivalent to an annualized yield of 8% on its 9.9% investment. In the first quarter of 2026, the Company recognized income of $1.1 million, which is net of $1.8 million of depreciation and amortization expense, related to the Company’s investment in Saber. Saber leases 53 operating facilities from the Company under a master lease with monthly contractual rent of $5.4 million as of March 31, 2026, and also operates 65 facilities owned by the Saber PropCo joint venture, in which the Company holds a 49% equity interest.

$75 Million in Q2 2026 Real Estate Investment Activity – In the second quarter of 2026, the Company completed $75.0 million of new investments, comprised of:

$42 Million Real Estate Acquisition – In April 2026, the Company acquired three facilities in Rhode Island for a contractual purchase price of $42.0 million. The Company will operate the facilities, through a new third-party property manager, utilizing a RIDEA structure. $33 Million Real Estate Acquisition – In April 2026, the Company acquired two facilities in Indiana for a contractual purchase price of $33.0 million and leased them to one existing operator. The investment has an initial annual cash yield of 10.0% with annual escalators of 2.0%. The operator’s lease, with $41.3 million in annual contractual rent before the acquisition, was extended from August 2027 to August 2036, concurrent with adding the acquired facilities to the master lease. Asset Sales:

$34 Million in Asset Sales – In the first quarter of 2026, the Company sold four facilities for $34.5 million in cash, recognizing a gain of $3.0 million.

Assets Held for Sale – As of March 31, 2026, the Company had 19 facilities classified as assets held for sale, totaling $233.1 million in net book value. These include 18 facilities leased to CommuniCare Health Services, Inc. (“CommuniCare”) that are part of a strategic disposition. These facilities, located throughout Maryland and West Virginia, were moved from assets held for use. In April 2026, 12 Maryland facilities were sold with the remaining six West Virginia expected to sell in the second quarter of 2026 for an expected aggregate total contractual purchase price of $479.9 million. There can be no assurance that the West Virginia facilities will be sold as expected. Contractual first quarter rent related to these 18 facilities was $9.2 million and, as of December 31, 2025, trailing 12-month EBITDAR coverage was 0.87x.

TRIPLE-NET AND MORTGAGE LOAN OPERATOR COVERAGE DATA

The following tables present operator revenue mix, census and coverage data based on information provided by the Company’s operators for the indicated periods. The Company has not independently verified this information and is providing this data for informational purposes only.

Operator Revenue Mix (1)

Medicare /

Private /

Medicaid

Insurance

Other

Three-months ended December 31, 2025

49.6

%

25.9

%

24.5

%

Three-months ended September 30, 2025

49.4

%

26.1

%

24.5

%

Three-months ended June 30, 2025

50.2

%

26.8

%

23.0

%

Three-months ended March 31, 2025

50.5

%

27.8

%

21.7

%

Three-months ended December 31, 2024

50.4

%

27.6

%

22.0

%

Coverage Data

Before

After

Occupancy (2)

Management

Management

Operator Census and Coverage (1)

Fees (3)

Fees (4)

Twelve-months ended December 31, 2025

82.6

%

1.94x

1.58x

Twelve-months ended September 30, 2025

82.6

%

1.93x

1.57x

Twelve-months ended June 30, 2025

82.6

%

1.91x

1.55x

Twelve-months ended March 31, 2025

82.2

%

1.88x

1.51x

Twelve-months ended December 31, 2024

81.8

%

1.88x

1.51x

FINANCING ACTIVITIES

ATM Program and Dividend Reinvestment and Common Stock Purchase Plan – The following is a summary of the common shares issued in the first quarter of 2026:

Dividend

Reinvestment and

At-the-Market

Common Stock

Program

Purchase Plan

Q1 2026

Number of shares (000’s)

2,219

9

Average price per share

$

48.08

$

47.12

Gross proceeds ($000’s)

$

106,684

$

438

BALANCE SHEET AND LIQUIDITY

As of March 31, 2026, the Company had $4.5 billion in outstanding indebtedness with a weighted average annual interest rate of 4.2%. The Company’s indebtedness consisted of an aggregate principal amount of $3.8 billion of senior unsecured notes, $425.0 million on its revolving credit facility, and $300.0 million on the 2028 Term Loan. As of March 31, 2026, total cash and cash equivalents were $26.1 million, and the Company had $1.6 billion in undrawn capacity under its unsecured revolving credit facility.

DIVIDENDS

On April 23, 2026, the Board of Directors declared a quarterly cash dividend of $0.67 per share, to be paid May 15, 2026, to common stockholders of record as of the close of business on May 4, 2026.

2026 GUIDANCE MID-POINT INCREASED

The Company’s expected 2026 Adjusted FFO range is between $3.19 to $3.25 per diluted share compared to the previous range of $3.15 and $3.25 per diluted share.

The guidance assumes:

all new investments disclosed above in the press release; no additional operators are placed on a cash-basis for revenue recognition; Genesis continues to pay its full contractual rental obligations of $13.3 million per quarter; Maplewood pays rent at $19.5 million per quarter; quarterly G&A expense of approximately $14 million to $15 million; no material changes in market interest rates or changes in foreign currency exchange rates, including those due to derivative instruments entered into to minimize the fluctuation in the GBP spot rates; $65 million of the $159 million in mortgages and other real estate-backed investments that are set to mature in 2026 will be converted from loans to fee simple real estate and the remaining balance will be repaid in 2026; $224 million in non-real estate backed loans at March 31, 2026 are expected to be repaid throughout 2026 (including $160 million in loans to Genesis to be repaid in Q4 2026); 18 CommuniCare facilities in assets held for sale on March 31st expected to be sold for $480 million; and no other asset sales beyond those described above. The Company’s guidance is based on several assumptions including those noted above, which are subject to change and many of which are outside the Company’s control. However, it excludes any additional:

acquisitions or acquisitions costs; capital markets activity; interest refinancing expenses; provisions for credit losses, if any; and certain revenue and expense items. If actual results vary from these assumptions, the Company's expectations may change. Without limiting the generality of the foregoing, the timing of collection of rental obligations from operators on a cash basis and the timing and completion of acquisitions, divestitures, restructurings and capital and financing transactions may cause actual results to vary materially from the Company’s current expectations. There can be no assurance that the Company will achieve its projected results. The Company may, from time to time, update its publicly announced AFFO guidance, but it is not obligated to do so.

The Company does not provide a reconciliation for its AFFO guidance to GAAP net income because it is unable to determine meaningful or accurate estimates of reconciling items without unreasonable effort. This is due to the inherent difficulty of forecasting the timing and/or amounts of various items that would impact future net income. This includes, but is not limited to, changes in the provision for credit losses, real estate impairments, acquisition, merger and transition related costs, straight-line write-offs, gain/loss on assets sold, etc. In particular, the Company is unable to predict with reasonable certainty the amount of change in the provision for credit losses in future periods, which is often a significant reconciling adjustment.

ADDITIONAL INFORMATION

Additional information regarding the Company can be found in its First Quarter 2026 Financial Supplemental posted under “Financial Info” in the Investors section of Omega’s website. The information contained on, or that may be accessed through, Omega’s website, including the information contained in the aforementioned supplemental, is not incorporated by any reference into, and is not part of, this document.

CONFERENCE CALL

The Company will be conducting a conference call on Wednesday, April 29, 2026, at 10 a.m. Eastern Time to review the Company’s 2026 first quarter results and current developments. Investors and other interested parties may access the conference call in the following ways:

At the Company’s website: https://www.omegahealthcare.com/ Via webcast: https://events.q4inc.com/attendee/811963547 . Joining via webcast is recommended for those who will not be asking questions. By telephone: The participant toll-free dial-in number is (800) 715-9871. The international dial-in is +1 (646) 307-1963. The conference ID number is 1388157. Webcast replays of the call will be available on Omega’s website for approximately two weeks following the call. Additionally, a copy of the earnings release will be available in the “Financial Information” section on the “Investors” page of Omega’s website.

Omega is a real estate investment trust (“REIT”) that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.

Forward-Looking Statements and Cautionary Language

This press release includes forward-looking statements within the meaning of the federal securities laws. All statements regarding Omega’s or its tenants’, operators’, borrowers’ or managers’ expected future financial condition, results of operations, cash flows, funds from operations, dividends and dividend plans, financing opportunities and plans, capital markets transactions, business strategy, budgets, projected costs, operating metrics, capital expenditures, competitive positions, acquisitions, investment opportunities, dispositions, facility transitions, growth opportunities, expected lease income, continued qualification as a REIT, plans and objectives of management for future operations and statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will” and other similar expressions are forward-looking statements. These forward-looking statements are inherently uncertain, and actual results may differ from Omega's expectations.

Omega’s actual results may differ materially from those reflected in such forward-looking statements as a result of a variety of factors, including, among other things: (i) uncertainties relating to the business operations of the operators of our assets, including those relating to reimbursement by third-party payors, regulatory matters, occupancy levels and quality of care, including the management of infectious diseases; (ii) our operators’ ability to manage industry challenges, including staffing shortages, which may impact certain regions more acutely, increased costs, and the sufficiency of governmental reimbursement rates to offset such costs and the conditions related thereto; (iii) additional regulatory and other changes in the healthcare sector, including changes to Medicaid and Medicare reimbursements, the potential impact of recent changes to state Medicaid funding levels as well as legislative and regulatory initiatives related to establishing minimum staffing requirements for skilled nursing facilities (“SNFs”) that may further exacerbate labor and occupancy challenges for Omega’s operators; (iv) the ability of any of Omega’s operators in bankruptcy to reject unexpired lease obligations, modify the terms of Omega’s mortgages and impede the ability of Omega to collect unpaid rent or interest during the pendency of a bankruptcy proceeding and retain security deposits for the debtor’s obligations, and other costs and uncertainties associated with operator bankruptcies; (v) changes in tax laws and regulations affecting REITs, including as the result of any federal or state policy changes driven by the current focus on capital providers to the healthcare industry; (vi) Omega’s ability to re-lease, otherwise transition or sell underperforming assets or assets held for sale on a timely basis and on terms that allow Omega to realize the carrying value of these assets or to redeploy the proceeds therefrom on favorable terms, including due to the potential impact of changes in the SNF and assisted living facility (“ALF”) markets or local real estate conditions; (vii) the availability and cost of capital to Omega; (viii) changes in Omega’s credit ratings and the ratings of its debt securities; (ix) competition in the financing of healthcare facilities; (x) competition in the long-term healthcare industry and shifts in the perception of various types of long-term care facilities, including SNFs and ALFs; (xi) changes in the financial position of Omega’s operators; (xii) the effect of economic, regulatory and market conditions generally, and particularly in the healthcare industry in the U.S. and in other jurisdictions where we conduct business, including the U.K.; (xiii) changes in interest rates and foreign currency exchange rates and the impact of inflation and changes in global tariffs and international trade disputes; (xiv) the timing, amount and yield of any additional investments; (xv) Omega’s ability to maintain its status as a REIT; (xvi) operational risks associated with our investments in healthcare operating companies, including senior housing properties managed through structures authorized by the REIT Investment Diversification and Empowerment Act of 2007 (commonly referred to as “RIDEA”); (xvii) the use of, or inability to use, artificial intelligence by us, our operators, managers, vendors and investors; (xviii) the effect of other factors affecting our business or the businesses of Omega’s operators that are beyond Omega’s or operators’ control, including natural disasters, public health crises or pandemics, cyber threats and governmental action, particularly in the healthcare industry, and (xix) other factors identified in Omega’s filings with the Securities and Exchange Commission. Statements regarding future events and developments and Omega’s future performance, as well as management’s expectations, beliefs, plans, estimates or projections relating to the future, are forward-looking statements.

We caution you that the foregoing list of important factors may not contain all the material factors that are important to you. Accordingly, readers should not place undue reliance on those statements. All forward-looking statements are based upon information available to us on the date of this release. We undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law.

OMEGA HEALTHCARE INVESTORS, INC.

CONSOLIDATED BALANCE SHEETS

(in thousands, except per share amounts)

March 31,

December 31,

2026

2025

(Unaudited)

ASSETS

Real estate assets

Buildings and improvements

$

7,696,967

$

7,901,652

Land

1,160,474

1,179,463

Furniture and equipment

531,005

539,775

Construction in progress

11,991

12,492

Total real estate assets

9,400,437

9,633,382

Less accumulated depreciation

(2,930,373)

(2,930,611)

Real estate assets – net

6,470,064

6,702,771

Real estate loans receivable – net

1,389,666

1,380,949

Investments in unconsolidated entities

507,720

414,127

Assets held for sale

233,128

4,000

Total real estate investments

8,600,578

8,501,847

Non-real estate loans receivable – net

354,953

330,322

Total investments

8,955,531

8,832,169

Cash and cash equivalents

26,149

27,024

Restricted cash

27,172

27,539

Contractual and other receivables – net

292,141

280,774

Goodwill

644,352

644,626

Other assets

289,206

236,927

Total assets

$

10,234,551

$

10,049,059

LIABILITIES AND EQUITY

Revolving credit facility

$

425,000

$

242,000

Senior notes and other unsecured borrowings – net

4,016,289

4,014,011

Accrued expenses and other liabilities

338,243

352,549

Total liabilities

4,779,532

4,608,560

Preferred stock $1.00 par value authorized – 20,000 shares, issued and outstanding – none

—

—

Common stock $0.10 par value authorized – 700,000 shares, issued and outstanding – 297,797 shares as of March 31, 2026 and 295,539 shares as of December 31, 2025

29,779

29,553

Additional paid-in capital

8,775,469

8,693,033

Cumulative net earnings

4,828,141

4,677,092

Cumulative dividends paid

(8,495,911)

(8,297,416)

Accumulated other comprehensive income

54,004

79,037

Total stockholders’ equity

5,191,482

5,181,299

Noncontrolling interest

263,537

259,200

Total equity

5,455,019

5,440,499

Total liabilities and equity

$

10,234,551

$

10,049,059

OMEGA HEALTHCARE INVESTORS, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

Unaudited

(in thousands, except per share amounts)

Three Months Ended

March 31,

2026

2025

Revenues

Rental income

$

266,864

$

228,375

Real estate tax and ground lease income

3,753

3,803

Real estate loans interest income

32,566

33,162

Non-real estate loans interest income

12,589

9,954

Resident fees and services

6,657

—

Miscellaneous income

526

1,491

Total revenues

322,955

276,785

Expenses

Depreciation and amortization

84,140

79,875

Interest expense

49,755

52,280

Senior housing operating expenses

5,427

—

General and administrative

14,995

13,321

Real estate tax and ground lease expense

4,016

3,826

Stock-based compensation expense

10,592

9,210

Severance expense

—

9,011

Acquisition, merger and transition related costs

1,114

1,464

Impairment on real estate properties

392

1,235

(Recovery) provision for credit losses

(3,294

)

5,092

Total expenses

167,137

175,314

Other income

Other income – net

1,076

3,047

Gain on assets sold – net

3,024

10,075

Total other income

4,100

13,122

Income before income tax expense and income from unconsolidated entities

159,918

114,593

Income tax expense

(5,106

)

(3,611

)

Income from unconsolidated entities

3,764

1,078

Net income

158,576

112,060

Net income attributable to noncontrolling interest

(7,527

)

(3,028

)

Net income available to common stockholders

$

151,049

$

109,032

Earnings per common share available to common stockholders:

Basic:

Net income available to common stockholders

$

0.47

$

0.34

Diluted:

Net income available to common stockholders

$

0.47

$

0.33

Dividends declared per common share

$

0.67

$

0.67

OMEGA HEALTHCARE INVESTORS, INC.

Nareit FFO, Adjusted FFO and FAD Reconciliation

Unaudited

(in thousands, except per share amounts)

Three Months Ended

March 31,

2026

2025

Net income (1)

$

158,576

$

112,060

Deduct gain from real estate dispositions

(3,024

)

(10,075

)

Sub-total

155,552

101,985

Elimination of non-cash items included in net income:

Depreciation and amortization

84,140

79,875

Depreciation – unconsolidated entities

9,412

683

Impairment on real estate properties

392

1,235

Nareit funds from operations (“Nareit FFO”)

$

249,496

$

183,778

Weighted-average common shares outstanding, basic

297,047

283,015

Restricted stock and PRSUs

3,014

3,703

Omega OP Units

15,067

8,210

Weighted-average common shares outstanding, diluted

315,128

294,928

Nareit funds from operations available per share

$

0.79

$

0.62

Adjustments to calculate adjusted funds from operations

Nareit FFO

$

249,496

$

183,778

Add back (deduct):

Stock-based compensation expense

10,592

9,210

Straight-line rent and other write-offs (2)

2,377

10,000

Acquisition, merger and transition related costs

1,114

1,464

Severance expense (3)

—

9,011

Non-cash (recovery) provision for credit losses

(1,051

)

7,579

Other normalizing items – net (4)

(2,855

)

355

Adjusted funds from operations (“AFFO”) (1)(5)

$

259,673

$

221,397

Adjustments to calculate funds available for distribution

Non-cash expense (6)

$

1,298

$

3,187

Capitalized interest

(136

)

(751

)

Non-cash revenue

(14,083

)

(13,022

)

Funds available for distribution (“FAD”) (1)(5)

$

246,752

$

210,811

__________________

(1)

The three months ended March 31, 2025 include the application of $4.3 million of security deposits (letters of credit and cash deposits) in revenue.

(2)

The three months ended March 31, 2025 includes a $10.0 million lease inducement recorded as a reduction to rental income related to a one-time payment made to an operator upon entering a new 10-year master lease.

(3)

The three months ended March 31, 2025 includes $6.6 million of non-cash stock-based compensation expense associated with the previously disclosed leadership transition that occurred in January 2025.

(4)

Primarily consists of cash interest received on seller financing loans related to asset sales not recognized, gains and losses associated with certain financial instruments and foreign currency and other normalizing revenue and expense adjustments for discrete items.

(5)

Adjusted funds from operations per share and funds available for distribution per share can be calculated using weighted-average common shares outstanding, diluted, as shown above.

(6)

Primarily consists of non-cash items within interest expense, such as the amortization of deferred financing fees and discounts, as well as the amortization of deferred gains from forward swaps designated as cash flow hedges and other non-cash items. For the three months ended March 31, 2025, Non-cash expense is not adjusted to include $2.4 million of amortization related to the above market loan assumed as part of the Cindat JV acquisition in July 2024. The above market loan was fully repaid in November 2025.

Nareit Funds From Operations (“Nareit FFO”), Adjusted FFO and Funds Available for Distribution (“FAD”) are non-GAAP financial measures. As used in this press release, GAAP refers to generally accepted accounting principles in the United States of America. The Company has provided reconciliations of the non-GAAP financial measures to the most directly comparable GAAP financial measures.

The Company calculates and reports Nareit FFO in accordance with the definition and interpretive guidelines issued by the National Association of Real Estate Investment Trusts (“Nareit”), and consequently, Nareit FFO is defined as net income (computed in accordance with GAAP), adjusted for the effects of asset dispositions and certain non-cash items, primarily depreciation and amortization and impairments on real estate assets, and after adjustments for unconsolidated partnerships and joint ventures and changes in the fair value of warrants. Adjustments for unconsolidated partnerships and joint ventures will be calculated to reflect funds from operations on the same basis. Revenue recognized based on the application of security deposits and letters of credit or based on the ability to offset against other financial instruments is included within Nareit FFO. The Company believes that Nareit FFO, Adjusted FFO and FAD are important supplemental measures of its operating performance. Because the historical cost accounting convention used for real estate assets requires depreciation (except on land), such accounting presentation implies that the value of real estate assets diminishes predictably over time, while real estate values instead have historically risen or fallen with market conditions. The term funds from operations was designed by the real estate industry to address this issue. Funds from operations described herein is not necessarily comparable to funds from operations of other real estate investment trusts, or REITs, that do not use the same definition or implementation guidelines or interpret the standards differently from the Company.

Adjusted FFO is calculated as Nareit FFO excluding the impact of non-cash stock-based compensation and certain revenue and expense items (e.g., acquisition, merger and transition related costs, straight-line rent and other write-offs, recoveries and provisions for credit losses (excluding certain cash recoveries on impaired loans), severance expense and other normalizing items). FAD is calculated as Adjusted FFO less non-cash expense, such as the amortization of deferred financing costs, and non-cash revenue, such as straight-line rent. FAD includes the non-cash amortization of premiums associated with the fair value of debt assumed in acquisitions. The Company believes these measures provide an enhanced measure of the operating performance of the Company’s core portfolio as a REIT. The Company’s computation of Adjusted FFO and FAD may not be comparable to the Nareit definition of funds from operations or to similar measures reported by other REITs, but the Company believes that they are appropriate measures for this Company.

The Company uses these non-GAAP measures among the criteria to measure the operating performance of its business. The Company also uses FAD among the performance metrics for performance-based compensation of officers. The Company further believes that by excluding the effect of depreciation, amortization, impairments on real estate assets and gains or losses from sales of real estate, all of which are based on historical costs, and which may be of limited relevance in evaluating current performance, funds from operations can facilitate comparisons of operating performance between periods. The Company offers these measures to assist the users of its financial statements in analyzing its operating performance. These non-GAAP measures are not measures of financial performance under GAAP and should not be considered as measures of liquidity or cash flow, alternatives to net income or indicators of any other performance measure determined in accordance with GAAP. Investors and potential investors in the Company’s securities should not rely on these non-GAAP measures as substitutes for any GAAP measure, including net income.

More News From Omega Healthcare Investors, Inc.

Omega Healthcare Investors is rated Buy, with strong long-term potential and a valuation reflecting elevated risk. OHI delivered a solid Q1, raised 2026 AFFO guidance to $3.19–$3.25 per share, and advanced its SHOP/RIDEA operational pivot. Risks include macro headwinds from the Iran conflict, higher rates, tenant pressures, and increased operational exposure from the SHOP model.

The Stability CaseQ1 2026 results showed clear improvement across the income statement. Revenue rose to $322.9M from $276.8M a year earlier, driven mainly by rental income growth and new senior housing operating revenue from RIDEA structures. Net income available to common stockholders reached $151.0M, or $0.47 per diluted share — up from $109.0M and $0.33 the prior year.

Cash generation strengthened in parallel. AFFO came in at $0.82 per share, FAD at $0.78. Operating cash flow of $215.5M comfortably covered $198.5M in common dividends. Management narrowed full-year AFFO guidance to $3.19–$3.25, and the payout ratio dropped to 82% of AFFO and 86% of FAD — meaningful headroom relative to prior years.

Liquidity remains intact. The company ended the quarter with $4.5 billion of debt, $26.1 million of cash, and $1.6 billion of undrawn revolver capacity, supplemented by ATM equity access through 2.2M shares issued for net proceeds of roughly $105.5M in the quarter.

Where Caution Is WarrantedThe same disclosures show stress at the operator level — the layer that sits underneath OHI’s financial statements but ultimately determines what flows through them.

Maplewood’s $329.5M revolver is on non-accrual, and Genesis is in Chapter 11, supported by a $25.0M Super-Priority DIP Loan plus two term loans totaling $134.5M. CommuniCare is the subject of a planned $479.9 million skilled nursing portfolio disposition involving 18 assets, with twelve already sold after quarter-end and six expected to close in Q2.

These aren’t isolated names. They reflect the structural reality that Omega’s coverage today depends on operating performance of skilled nursing operators whose own coverage is tied to a federal-state reimbursement environment they don’t control. When that environment tightens, the pressure shows up on the operator’s income statement first — and on OHI’s only when leases or loans are restructured.

What Would Shift The NarrativeWhat I’d WatchThis is not a prediction — structural assessment.

This essay applies the DFB Signal Frameworks — Three Clocks™, BBB- Cliff™, and Buffer Half-Life™. More structural income notes are published at Dividend Forensics Bureau.

Source: Omega Healthcare Investors Q1 2026 Earnings Release (April 28, 2026); Form 10-Q (Q1 2026); Q1 2026 earnings call transcript (April 29, 2026).

Benzinga Disclaimer: This article is from an unpaid external contributor. It does not represent Benzinga’s reporting and has not been edited for content or accuracy.

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.

Taylor Pickett, CEO, to retire October 1st; stepping down from Board of Directors

Matthew Gourmand, President, promoted to CEO; to join Board

Bob Stephenson, CFO, to retire August 1st

Neal Ballew, CAO, promoted to CFO

HUNT VALLEY, Md.--(BUSINESS WIRE)--Omega Healthcare Investors, Inc. (NYSE: OHI) (the “Company” or “Omega”) today announced that Matthew Gourmand, President of Omega, will become the Company’s Chief Executive Officer in conjunction with the planned retirement of Taylor Pickett effective October 1, 2026. Mr. Pickett will step down from the Board of Directors upon his retirement, and the Board of Directors intends to appoint Mr. Gourmand to the Board, effective on that date.

Omega also announced the planned retirement of Bob Stephenson as the Company’s Chief Financial Officer effective August 1, 2026, with Neal Ballew, currently Omega’s Chief Accounting Officer of six years, succeeding Mr. Stephenson in that role.

Craig Callen, Chair of the Board of Directors, stated, “I am excited to announce the next generation leadership of Omega, with Matthew and Neal stepping up into the CEO and CFO roles as the culmination of a carefully managed, multi-year succession plan. The Board has been developing this plan over an extended period and believes it will lead to Omega’s continued success.”

Mr. Callen continued regarding Mr. Gourmand, “We have had the opportunity to see Matthew evolve in various roles and, with his deep investing experience and a leadership style rooted in collaboration and innovation, he is well-prepared to lead the Company in its next phase of growth.”

Mr. Pickett stated, “Having worked with Matthew for the past eight years, I believe he is the right person to take the Company forward. With a highly experienced and driven team to support him, I am confident that Omega is well-positioned to continue to increase shareholder value.”

Mr. Pickett’s retirement marks the end of a remarkable 25 years as Omega’s CEO, during which Omega has achieved a total shareholder return of over 10,000%, the highest return of all publicly traded REITs over that period. Its portfolio of predominantly senior care assets grew from 258 to 1,124 as of the past quarter, and its market capitalization increased from approximately $60 million to over $15 billion today.

Mr. Callen commented, “Throughout Taylor’s 25 years as CEO of Omega, his strategic vision and strong leadership have created an industry-leading company well-positioned to capture current and future demographic trends. Taylor created a strong culture based on achievement, prudent capital allocation and development of future executives. That team now stands ready to build upon this success.”

Mr. Stephenson also has had a remarkable career at Omega, overseeing significant growth in the capital base and the establishment of investment grade credit ratings, reflecting strong balance sheet management.

Mr. Pickett stated, “During Bob’s 25-year tenure as CFO, his financial management has been exceptional. He inherited a deeply challenged balance sheet, which he has methodically and judiciously strengthened over the years. He leaves Omega as an investment-grade credit, with a well-laddered maturity schedule, and leverage near all-time lows, with Neal very well-trained and ready to step up. I would like to thank Bob for being such a great partner to me in the leadership of Omega.”

Mr. Callen continued, “We thank both Taylor and Bob for their unwavering service to shareholders and wish each of them a long and well-deserved retirement.”

Mr. Pickett said, “It has been an honor and a privilege to lead Omega since 2001. I am proud of our team’s many accomplishments, and I am grateful to my colleagues, our Board of Directors, our operating partners, and all those who have contributed to Omega’s success during my tenure.”

Mr. Stephenson commented, “It has been the highlight of my professional life to be part of the Omega leadership team and oversee the financial evolution and growth of the Company from its early day struggles to its present position as a large scale, financially sound industry leader.”

Mr. Stephenson continued, “I have worked very closely with Neal since he joined Omega. He is highly skilled, bright, and talented, and will provide great continuity. As we start a multi-decade tailwind from the aging of the baby boomers, and with Matthew and Neal ready to step into their new roles, I feel as confident about the future of Omega as I feel proud of the past.”

Reflecting on his impending new role, Mr. Gourmand noted, “I am excited to serve as Omega’s next CEO and lead this exceptional team in its next chapter. I am grateful for the trust that the Board has placed in me, and I will work tirelessly to repay that trust. I want to thank Taylor and Bob for growing and shaping Omega into what it is today, as well as all their mentorship and counsel to prepare me for this next step. They will be deeply missed, but the culture of excellence and an unwavering focus on creating shareholder value will continue.”

Both Mr. Pickett and Mr. Stephenson have agreed to remain in consulting roles after their retirements, being available to the Company as requested from time to time during their consulting periods.

Omega is a real estate investment trust (“REIT”) that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.

Forward-Looking Statements and Cautionary Language

This press release includes forward-looking statements within the meaning of the federal securities laws. All statements regarding Omega’s or its tenants’, operators’, borrowers’ or managers’ expected future financial condition, results of operations, cash flows, funds from operations, dividends and dividend plans, financing opportunities and plans, capital markets transactions, business strategy, budgets, projected costs, operating metrics, capital expenditures, competitive positions, acquisitions, investment opportunities, dispositions, facility transitions, growth opportunities, expected lease income, continued qualification as a REIT, plans and objectives of management for future operations and statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will” and other similar expressions are forward-looking statements. These forward-looking statements are inherently uncertain, and actual results may differ from Omega's expectations.

Omega’s actual results may differ materially from those reflected in such forward-looking statements as a result of a variety of factors, including, among other things: (i) uncertainties relating to the business operations of the operators of our assets, including those relating to reimbursement by third-party payors, regulatory matters, occupancy levels and quality of care, including the management of infectious diseases; (ii) our operators’ ability to manage industry challenges, including staffing shortages, which may impact certain regions more acutely, increased costs, and the sufficiency of governmental reimbursement rates to offset such costs and the conditions related thereto; (iii) additional regulatory and other changes in the healthcare sector, including changes to Medicaid and Medicare reimbursements, the potential impact of recent changes to state Medicaid funding levels as well as legislative and regulatory initiatives related to establishing minimum staffing requirements for skilled nursing facilities (“SNFs”) that may further exacerbate labor and occupancy challenges for Omega’s operators; (iv) the ability of any of Omega’s operators in bankruptcy to reject unexpired lease obligations, modify the terms of Omega’s mortgages and impede the ability of Omega to collect unpaid rent or interest during the pendency of a bankruptcy proceeding and retain security deposits for the debtor’s obligations, and other costs and uncertainties associated with operator bankruptcies; (v) changes in tax laws and regulations affecting REITs, including as the result of any federal or state policy changes driven by the current focus on capital providers to the healthcare industry; (vi) Omega’s ability to re-lease, otherwise transition or sell underperforming assets or assets held for sale on a timely basis and on terms that allow Omega to realize the carrying value of these assets or to redeploy the proceeds therefrom on favorable terms, including due to the potential impact of changes in the SNF and assisted living facility (“ALF”) markets or local real estate conditions; (vii) the availability and cost of capital to Omega; (viii) changes in Omega’s credit ratings and the ratings of its debt securities; (ix) competition in the financing of healthcare facilities; (x) competition in the long-term healthcare industry and shifts in the perception of various types of long-term care facilities, including SNFs and ALFs; (xi) changes in the financial position of Omega’s operators; (xii) the effect of economic, regulatory and market conditions generally, and particularly in the healthcare industry in the U.S. and in other jurisdictions where we conduct business, including the U.K.; (xiii) changes in interest rates and foreign currency exchange rates and the impact of inflation and changes in global tariffs and international trade disputes; (xiv) the timing, amount and yield of any additional investments; (xv) Omega’s ability to maintain its status as a REIT; (xvi) operational risks associated with our investments in healthcare operating companies, including senior housing properties managed through structures authorized by the REIT Investment Diversification and Empowerment Act of 2007 (commonly referred to as “RIDEA”); (xvii) the use of, or inability to use, artificial intelligence by us, our operators, managers, vendors and investors; (xviii) the effect of other factors affecting our business or the businesses of Omega’s operators that are beyond Omega’s or operators’ control, including natural disasters, public health crises or pandemics, cyber threats and governmental action, particularly in the healthcare industry, and (xix) other factors identified in Omega’s filings with the Securities and Exchange Commission. Statements regarding future events and developments and Omega’s future performance, as well as management’s expectations, beliefs, plans, estimates or projections relating to the future, are forward-looking statements.

We caution you that the foregoing list of important factors may not contain all the material factors that are important to you. Accordingly, readers should not place undue reliance on those statements. All forward-looking statements are based upon information available to us on the date of this release. We undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law.

More News From Omega Healthcare Investors, Inc.

Omega Healthcare Investors offers a compelling high-yield opportunity after a recent price pullback, now yielding over 6%. OHI's fundamentals are robust, with FAD per share up 9.5% YoY, improved dividend coverage at 86%, and tenant rent coverage at a decade high. Strategic expansion into RIDEA structures and value-added acquisitions positions OHI for potentially strong total returns.